South San Francisco, CA Breaking News Headlines Today

News about South San Francisco

Stay current with all the latest and breaking news about South San Francisco, compare headlines and perspectives between news sources on stories happening today. In total, 95 stories have been published about South San Francisco which Ground News has aggregated in the past 3 months.

Local News Publishers

Untracked bias

Suggest a source

Looking for a source we don't already have? Suggest one here.

Septerna, Inc. (SEPN) Stock Analysis: A Biotech Growth Story With Impressive Revenue Surge

Septerna, Inc. (SEPN), a dynamic player in the biotechnology sector, has captivated investor interest with its remarkable financial performance and innovative approach to tackling complex diseases. Based in South San Francisco, California, Septerna is pioneering the development of oral small molecule therapies targeting G protein-coupled receptors (GPCRs) to address a wide spectrum of diseases including endocrinology, immunology, and metabolic d…South San Francisco · South San Francisco Read Article

Navigating the Challenges and Opportunities A Closer Look at Cytokinetics, Inc. Amid Shareholder Investigations

As the landscape of investment continues to shift, long-term shareholders of Cytokinetics, Inc. (NASDAQ: CYTK) and three other notable companies find themselves amid scrutiny that can potentially reshape their portfolios. Grabar Law Office, a firm known for its shareholder advocacy, has made an important announcement concerning ongoing investigations into the actions and performance of Cytokinetics, Fortrea Holdings, Inc. (NASDAQ: FTRE), Inspire…South San Francisco · South San Francisco Read Article

ON Partners Recruits Chief Business Officer for CytomX Therapeutics

Partner Suzanne Zebedee of ON Partners recently placed Rachael Lester as senior vice president and chief business officer of NASDAQ-traded CytomX Therapeutics, Inc. in South San Francisco, CA. “Rachael brings a wealth of experience in strategic planning and business development across the biopharmaceutical industry and joins CytomX at a time when our platform and pipeline are well positioned to deliver meaningful advances in the treatment of man…South San Francisco · South San Francisco Read Article

Erasca to Present at the 8th Annual Evercore Healthcare Conference

100% Right coverage: 1 sources

SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and...South San Francisco · South San Francisco See the Story

Exelixis (NASDAQ:EXEL) EVP Sells $1,431,751.56 in Stock

Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) EVP Patrick Haley sold 34,187 shares of the stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $41.88, for a total transaction of $1,431,751.56. The transaction was disclosed in a legal filing with the SEC, which is available […]SEC · South San Francisco Read Article

Former Winston-Salem Journal Sportswriter Receives Heart Transplant

100% Left coverage: 2 sources

"How have I not gone nuts?" he asked, anticipating an obvious question. "That's my third pile of books. I think I've read 23 so far. I had Braves games before, and now the Hurricanes and college football.South San Francisco · South San Francisco See the Story

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring A 35% Upside Potential In Biotechnology

Theravance Biopharma, Inc. (NASDAQ: TBPH) presents an intriguing opportunity for savvy investors with its promising potential upside of 35.01%, as indicated by the average target price of $24.17 against its current price of $17.90. Operating within the dynamic biotechnology sector, Theravance’s strategic focus on developing and commercializing novel therapeutics positions it well for future growth. #### Company Snapshot Theravance Biopharma, bas…South San Francisco · South San Francisco Read Article

News about South San Francisco

News about South San Francisco

Local News Publishers Too Big Arrow Icon

7 Companies Hiring in South San Francisco

Nkarta to Participate in Evercore Healthcare Conference

Suspect Dead after San Francisco SWAT Standoff – ONSCENE.TV

Septerna, Inc. (SEPN) Stock Analysis: A Biotech Growth Story With Impressive Revenue Surge

Navigating the Challenges and Opportunities A Closer Look at Cytokinetics, Inc. Amid Shareholder Investigations

ON Partners Recruits Chief Business Officer for CytomX Therapeutics

Erasca to Present at the 8th Annual Evercore Healthcare Conference

Exelixis (NASDAQ:EXEL) EVP Sells $1,431,751.56 in Stock

Former Winston-Salem Journal Sportswriter Receives Heart Transplant

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring A 35% Upside Potential In Biotechnology

Local News Publishers Too Big Arrow Icon

7 Companies Hiring in South San Francisco

Nkarta to Participate in Evercore Healthcare Conference

Suspect Dead after San Francisco SWAT Standoff – ONSCENE.TV

Septerna, Inc. (SEPN) Stock Analysis: A Biotech Growth Story With Impressive Revenue Surge

Navigating the Challenges and Opportunities A Closer Look at Cytokinetics, Inc. Amid Shareholder Investigations

ON Partners Recruits Chief Business Officer for CytomX Therapeutics

Erasca to Present at the 8th Annual Evercore Healthcare Conference

Exelixis (NASDAQ:EXEL) EVP Sells $1,431,751.56 in Stock

Former Winston-Salem Journal Sportswriter Receives Heart Transplant

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring A 35% Upside Potential In Biotechnology

Local News Publishers

Local News Publishers